Saliva Diagnostics (SALV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shadow who wrote (2083)	2/16/1998 2:17:00 PM
From: rl	Read Replies (1) of 3369

You are the only one who gets it. The Swiss deal has ABSOLUTELY NOTHING to do with any belief in SALV or its product and management. It is only a stock transaction. These deals are done regularly, primarily out of Switzerland, Ireland, the Bahamas and other places. $1.5 million is only enough to keep the doors open and not to start the FDA campaign. The good news in all this is that SALV will stay afloat for another year. Believing that the Swiss investors will assist in any way but with the money is completely naive. I suppose that is plenty. They will be totally out of this stock within 7 months. If they made enough money, they'll do it again.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next